Development, Implementation & Evaluation of the Impact of a Guideline in

Status Completed

Clinical Trial Summary

The aim of this study is to evaluate the impact of a clinical guideline in cardiovascular risk, with a local adaptation model of the existing guidelines in clinical practise at present, of each of the different cardiovascular risk factors, and the implementation strategy.

Clinical Trial Description

With this objective this study will be developed in three diferent phases. The guideline in clinical practice elaboration. It will be based in evidence medicine and it will be adapted based in the cardiovascular risk factors guidelines published at the present.

The spreding and implementation of the guideline between the sanitarians, as much in primary medicine as in specialised area, involved in the care of the patient in cardiovascular risk, in the Area 2 in Madrid.

And the evaluation of the implementation strategy, used between the primary care physicians.

For the local adaptation, will be used a systematic review of the different guidelines in the Spanish and international literature, published in the last years about this topic.

The ones with better quality criteria will be selected and doctors and nurses related from different specialities, involved in the cardiovascular illness, as much as members of the staff of the medical management an nursery, will be invited to participate in the selection of the recommendations of the guides and in the search of the consensus. After that, this guide will be given to a group of patients, who will be asked for a critical approach and their suggestions will be applied.

The evaluation will be done with a clinical trial designe , testing the use of the guide and its results on health intermediary variables. With this objective the results with an implementation technique based on opinion leaders plus computer reminder, will be evaluated, instead of using the standard implementation. ;

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Health Services Research

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01270022
Study type	Interventional
Source	Gerencia De Atencion Primaria Area 2 De Madrid
Contact
Status	Completed
Phase	N/A
Start date	January 2004
Completion date	July 2010

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT06405880` - Pharmacist Case Finding and Intervention for Vascular Prevention Trial	N/A
Completed	`NCT02589769` - Effects of Reduction in Saturated Fat on Cholesterol and Lipoproteins in Lean and Obese Persons	N/A
Recruiting	`NCT01902654` - Osteoarthritis Cardiovascular Risk Factors	N/A
Completed	`NCT01698034` - Volunteering and Cardiovascular Risk in Adolescents	N/A
Recruiting	`NCT01231152` - The Impact of Obesity on Children and Adolescents.	N/A
Completed	`NCT00983333` - Initial Test of the Time to Talk CARDIO (Creating a Real Dialogue In the Office) Program	N/A
Terminated	`NCT00527436` - Fish Oil and Biomarkers of Cardiovascular Risk	N/A
Recruiting	`NCT02917928` - The Potential of Carnosine Supplementation in Optimising Cardiometabolic Health	Phase 2
Active, not recruiting	`NCT02490683` - Effects of Soy Based Dietary Supplements on Cardiometabolic Risk Factors.	N/A
Recruiting	`NCT02282748` - Swiss Longitudinal Cohort
Completed	`NCT01252316` - Cardiopulmonary Resuscitation (CPR) Dissemination Study Using Nurses and Volunteers	Phase 1/Phase 2
Completed	`NCT01190592` - Resistance Training With Milk Supplementation in Adolescents	N/A
Completed	`NCT00787306` - Cardiovascular Health And Risk Modification in Family Health Teams	Phase 3
Withdrawn	`NCT01087411` - Intervention Study to Prevent Obesity in Sedentary 8 Year Old Swedish Children	N/A
Completed	`NCT01260441` - An In-Hospital Family Member Cardiopulmonary Resuscitation (CPR) Education Program	Phase 1
Completed	`NCT04025463` - Healing Our Hearts Minds and Bodies: CVD Reduction in Persons With HIV	N/A
Completed	`NCT02922920` - Effects of Tart Cherry Juice on the Body	N/A
Completed	`NCT01514656` - CPR Training: Video Self-Instruction Kit or Video-Only	N/A
Completed	`NCT01134029` - Planned CORR: Planned Care for Obesity and Risk Reduction	N/A
Active, not recruiting	`NCT00786890` - A Survey to Evaluate the Cardiovascular Risk Status of Subjects With Pre-Diabetes in Hong Kong	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Development, Implementation and Evaluation of the Impact of a Guideline in Clinical Practise for Cardiovascular Risk

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms